These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 938964)
1. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Britt BA; Endrenyi L; Peters PL; Kwong FH; Kadijevic L Can Anaesth Soc J; 1976 May; 23(3):263-84. PubMed ID: 938964 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia. Ellis FR; Clarke IM; Modgill M; Currie S; Harriman DG Br Med J; 1975 Aug; 3(5982):511-3. PubMed ID: 1164612 [TBL] [Abstract][Full Text] [Related]
3. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia. Meltzer HY; Hassan SZ; Russo P; Cho HW Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694 [TBL] [Abstract][Full Text] [Related]
4. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia. Isherwood DM; Ridley J; Wilson J Br J Obstet Gynaecol; 1975 Apr; 82(4):346-9. PubMed ID: 1125158 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum creatine phosphokinase activity for the porcine malignant hyperthermia syndrome. Heffron JJ; Mitchell G Anesth Analg; 1975; 54(4):536-9. PubMed ID: 1170791 [TBL] [Abstract][Full Text] [Related]
6. Identification of susceptibility to malignant hyperpyrexia. Moulds RF; Denborough MA Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071 [TBL] [Abstract][Full Text] [Related]
7. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Monnier N; Krivosic-Horber R; Payen JF; Kozak-Ribbens G; Nivoche Y; Adnet P; Reyford H; Lunardi J Anesthesiology; 2002 Nov; 97(5):1067-74. PubMed ID: 12411788 [TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia: a possible new variant. Lee DS; Adams JP; Zimmerman JE Can Anaesth Soc J; 1985 May; 32(3 Pt 1):268-71. PubMed ID: 4005678 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl)]. Morikawa S; Murata M; Murata H; Iwai S Masui; 1979 Feb; 28(2):187-96. PubMed ID: 423358 [No Abstract] [Full Text] [Related]
12. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. Paasuke RT; Brownell AK JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979 [TBL] [Abstract][Full Text] [Related]
13. Letter: Serum creatine phosphokinase and malignant hyperpyrexia. Ryan DW; Appleyard TN Br Med J; 1976 Jan; 1(6001):96. PubMed ID: 1244960 [No Abstract] [Full Text] [Related]
15. Malignant hyperpyrexia: Investigation of a family after a fatal case. Ryan DW; Appleyard TN Br J Anaesth; 1975 Sep; 47(9):1001-4. PubMed ID: 1191461 [TBL] [Abstract][Full Text] [Related]
16. Investigation of malignant hyperthermia in Denmark and Sweden. Ording H; Ranklev E; Fletcher R Br J Anaesth; 1984 Nov; 56(11):1183-90. PubMed ID: 6487440 [TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia. Bandschapp O; Girard T Swiss Med Wkly; 2012; 142():w13652. PubMed ID: 22851008 [TBL] [Abstract][Full Text] [Related]
18. The genetics of malignant hyperthermia: evidence for heterogeneity. McPherson E; Taylor CA Am J Med Genet; 1982 Mar; 11(3):273-85. PubMed ID: 7081293 [TBL] [Abstract][Full Text] [Related]